<p><h1>Zoster Vaccine Live Market Size 2024 - 2031 Global Industrial Analysis, Key Geographical Regions, Market Share, Top Key Players, Product Types and Forecast Research Report</h1></p><p><strong>Zoster Vaccine Live Market Analysis and Latest Trends</strong></p>
<p><p>Zoster Vaccine Live, also known as the shingles vaccine, is a live attenuated vaccine that helps prevent shingles in adults over the age of 50. The vaccine works by boosting the immune system to reduce the risk of developing shingles, which is caused by the varicella-zoster virus. The Zoster Vaccine Live Market is expected to grow at a CAGR of 4.8% during the forecast period.</p><p>The increasing prevalence of shingles among the aging population, along with the growing awareness about the importance of preventive healthcare, is driving the growth of the Zoster Vaccine Live Market. Additionally, advancements in vaccine technology and government initiatives to promote vaccination programs are further contributing to the market growth.</p><p>The latest trends in the Zoster Vaccine Live Market include the development of combination vaccines that offer protection against multiple diseases, as well as the expansion of distribution channels to reach a wider population. Furthermore, ongoing research and development activities to improve the efficacy and safety of the vaccine are expected to drive innovation in the market.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1669353">https://www.reliableresearchreports.com/enquiry/request-sample/1669353</a></p>
<p>&nbsp;</p>
<p><strong>Zoster Vaccine Live Major Market Players</strong></p>
<p><p>Zoster Vaccine Live is a market dominated by two key players - Merck and GSK (GlaxoSmithKline). Merck's Zostavax and GSK's Shingrix are the two main vaccines available for the prevention of shingles caused by the varicella-zoster virus.</p><p>Merck is a leading pharmaceutical company with a strong presence in the global healthcare market. The company's Zostavax vaccine has been on the market for several years and has been widely used for the prevention of shingles. However, in recent years, the introduction of GSK's Shingrix has posed significant competition to Merck's dominance in the market.</p><p>GSK's Shingrix has been gaining market share rapidly due to its higher efficacy and better safety profile compared to Zostavax. The strong sales growth of Shingrix has propelled GSK to the forefront of the Zoster Vaccine Live market, surpassing Merck's Zostavax in terms of market share and revenue.</p><p>Both Merck and GSK are continuing to invest in research and development to further improve their respective vaccines and expand their market presence. With the growing awareness of the importance of vaccination against shingles, the market for Zoster Vaccine Live is expected to continue growing in the coming years.</p><p>In terms of sales revenue, GSK reported sales of $1.36 billion for Shingrix in 2020, representing a significant increase from the previous year. Merck's sales revenue for Zostavax was not disclosed, but it is estimated to be lower than that of GSK's Shingrix.</p><p>Overall, the Zoster Vaccine Live market is a competitive landscape dominated by Merck and GSK, with the latter gaining momentum with the introduction of Shingrix. Both companies are expected to continue leading the market and driving growth through innovation and market expansion.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Zoster Vaccine Live Manufacturers?</strong></p>
<p><p>The Zoster Vaccine Live market has witnessed steady growth in recent years, driven by increasing awareness about the importance of vaccination to prevent shingles. The market is expected to continue growing, as the aging population and rising healthcare expenditures drive demand for preventive healthcare measures. The future outlook for the Zoster Vaccine Live market looks promising, with advancements in vaccine technology and ongoing research efforts contributing to the development of more effective and efficient vaccines. Overall, the market is projected to experience sustained growth in the coming years, presenting opportunities for market players to expand their presence and offerings.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1669353">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1669353</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Zoster Vaccine Live Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Monovalent Vaccine</li><li>Combination Vaccine</li></ul></p>
<p><p>Zoster Vaccine Live market includes two types of vaccines - monovalent vaccine and combination vaccine. The monovalent vaccine contains only one strain of the live virus to protect against shingles, while the combination vaccine includes multiple strains of the live virus for added protection. Both vaccines are used to prevent shingles, a painful viral infection that mainly affects older adults. Each type of vaccine offers different levels of protection and may be recommended based on individual risk factors and medical history.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1669353">https://www.reliableresearchreports.com/purchase/1669353</a></p>
<p>&nbsp;</p>
<p><strong>The Zoster Vaccine Live Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Kids Injection</li><li>Adults Injection</li></ul></p>
<p><p>Zoster Vaccine Live is utilized in both kids and adults as an injection to provide protection against shingles caused by the varicella-zoster virus. In the kids injection market, it is used to prevent shingles in children, while in the adults injection market, it is used to reduce the risk of developing shingles in adults. Both applications target specific age groups to offer protection against this painful and potentially debilitating condition.</p></p>
<p><a href="https://www.reliableresearchreports.com/zoster-vaccine-live-r1669353">&nbsp;https://www.reliableresearchreports.com/zoster-vaccine-live-r1669353</a></p>
<p><strong>In terms of Region, the Zoster Vaccine Live Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The Zoster Vaccine Live market is expected to witness significant growth in regions such as North America, Europe, USA, APAC, and China. Among these regions, North America and Europe are anticipated to dominate the market with a combined market share of over 60%. The increasing prevalence of herpes zoster, growing geriatric population, and rising awareness about preventive healthcare measures are driving the growth of the market in these regions. APAC and China are also expected to contribute substantially to the market growth.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1669353">https://www.reliableresearchreports.com/purchase/1669353</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1669353">https://www.reliableresearchreports.com/enquiry/request-sample/1669353</a></p>
<p><strong></strong></p>
<p><p><a href="https://github.com/laurenreichert/Market-Research-Report-List-2/blob/main/5101990177754.md">軍用セラミックコンデンサ</a></p><p><a href="https://github.com/alexxisgm/Market-Research-Report-List-1/blob/main/landscaping-software-market.md">Landscaping Software Market</a></p></p>